(INNS)
TAMTUVETMAB(SLE)
TAMTUVETMAB(INNC)
IMMUNOGLOBULIN G2_V-KAPPA-C-LAMBDA, ANTI-[CANIS LUPUS FAMILIARIS CD52], CANINIZED MONOCLONAL ANTIBODY; GAMMA2 HEAVY CHAIN CHIMERIC (1-456) [CHIMERIC VH (RATTUS NORVEGICUS IGHV7S6*01 (97.00%) -(IGHD) -CANIS LUPUS FAMILIARIS IGHJ-E2RCC8) [8.10.12] (1-121) -CANIS LUPUS FAMILIARIS IGHG2*02 (CH1 (122-219), HINGE (220- 237), CH2 (238-347), CH3 (348-454), CHS (455- 456))(122-456)], (136-212')-DISULFIDE WITH V-KAPPA- C-LAMBDA LIGHT CHAIN CHIMERIC (1'-213') [RATTUS NORVEGICUS V-KAPPA (RATTUS NORVEGICUS IGKV22S7 (93.70%) - IGKJ1*01) [6.3.9] (1'-107') -CANIS LUPUS FAMILIARIS IGLC1S1*01 V45.3>I (156) (108'-213')]; DIMER (233- 233'':236-236'')-BISDISULFIDE, RECOMMENDED INN: LIST 76, PROPOSED LIST 124(WHO)
TAMTUVETMABUM(INN)